About
Dr. Raj Bawa is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, VA, USA that he founded in 2002. He is an inventor, entrepreneur, professor and registered patent agent licensed to practice before the U.S. Patent & Trademark Office. Currently, he serves as a scientific advisor to Teva Pharma, Israel, is a visiting research scholar at the Pharmaceutical Research Institute of Albany College of Pharmacy in Albany, NY, and is vice president of Guanine, Inc., based in Rensselaer, NY. Previously, he was an adjunct professor at Rensselaer Polytechnic Institute in Troy, NY from 1999- 2016, from where he received his doctoral degree in three years (biophysics/biochemistry). He has served as a principal investigator and reviewer for both the NIH and NSF. Currently, he is principal investigator of a CDC SBIR grant to develop an assay for carbapenemase-resistant bacteria. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner from 1996-2002. He is a life member of Sigma Xi and co-chair of the nanotech and personalized medicine committees of the American Bar Association. In 2008, he along with Dr. Esther Chang of Georgetown Medical Center, founded the American Society for Nanomedicine where he serves as founding director. He has authored over 100 publications, co-edited five texts and serves on the editorial boards of a dozen peer-reviewed journals. Some of Dr. Bawa’s awards include the Innovations Prize from the Institution of Mechanical Engineers, London, UK (2008); Appreciation Award from the Undersecretary of Commerce, Washington, DC (2001); the Key Award from Rensselaer’s Office of Alumni Relations (2005); and Lifetime Achievement Award from the American Society for Nanomedicine (2014).